Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Refining Treatment Options for Trichomonas Vaginalis Infection in Women and Men: A Comparative Analysis of Oral Multi-Dose Metronidazole and Single-Dose Secnidazole

NCT06261840 is registered in ClinicalTrials.gov with Tulane University as lead sponsor.

NCT NCT06261840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06261840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Refining Treatment Options for Trichomonas Vaginalis Infection in Women and Men: A Comparative Analysis of Oral Multi-Dose Metronidazole and Single-Dose Secnidazole
Lead sponsor
Tulane University
Phase
Phase 4
Overall status
Recruiting
Start date
May 6, 2025
Completion date
July 31, 2029
Enrollment
1,200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginitis, trichomonas vaginitis